Trials / Unknown
UnknownNCT03640130
Peripheral Reading
Factors Limiting Peripheral Reading
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- University of Houston · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate reading performance in the visual periphery by simulating central vision loss using a computer-controlled gaze-contingent display with an eye tracker. Participants will read a page of text at a comfortable rate. Several manipulations hypothesized to improve reading will be tested, such as an inverted-text "spotlight" of a single word that follows the participant's gaze.
Detailed description
Participants will view paragraphs of multiple sentences of text with their central vision blocked computationally with a "simulated scotoma." Participants will be free to move their eyes around the page of text at a comfortable rate. The three outcomes described elsewhere will be evaluated. In different blocks, text will contain one or more of several dynamic assistive manipulations that are hypothesized to enhance reading: 1) inverting the text at a given position, with instructions for the participant to attend to that location, which simulates a "surrogate fovea" of a patient with central vision loss. 2) horizontally expanding text to alleviate within-word crowding. 3) highlighting the next word with a visible indicator to encourage proper eye movements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Gaze-contingent text enhancement | In different testing blocks, the efficacy of the different enhancements will be evaluated, such as inverting the text in a gaze-contingent inverted "spotlight." |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2018-08-21
- Last updated
- 2018-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03640130. Inclusion in this directory is not an endorsement.